BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26305308)

  • 1. Clinical Effect of Percutaneous Radiofrequency Ablation for Residual Lung Metastases from Breast Cancer After Systemic Chemotherapy.
    Wang Y; Lu X; Wang Y; Zhou J
    J Coll Physicians Surg Pak; 2015 Aug; 25(8):602-5. PubMed ID: 26305308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study).
    Seidensticker M; Garlipp B; Scholz S; Mohnike K; Popp F; Steffen I; Seidensticker R; Stübs P; Pech M; PowerskI M; Hass P; Costa SD; Amthauer H; Bruns C; Ricke J
    BMC Cancer; 2015 Jul; 15():517. PubMed ID: 26169362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience.
    Fanucchi O; Ambrogi MC; Aprile V; Cioni R; Cappelli C; Melfi F; Massimetti G; Mussi A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):57-64. PubMed ID: 27059068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
    Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
    AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
    White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
    Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases.
    Li X; Wang J; Li W; Huang Z; Fan W; Chen Y; Shen L; Pan T; Wu P; Zhao M
    Int J Hyperthermia; 2012; 28(8):721-8. PubMed ID: 23153217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
    Mahnken AH; Bruners P; Tacke JA; Günther RW
    Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival.
    Mazzaglia PJ; Berber E; Milas M; Siperstein AE
    Surgery; 2007 Jul; 142(1):10-9. PubMed ID: 17629995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA).
    Nour-Eldin NA; Exner S; Al-Subhi M; Naguib NNN; Kaltenbach B; Roman A; Vogl TJ
    Int J Hyperthermia; 2017 Nov; 33(7):820-829. PubMed ID: 28540791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation.
    Pan CC; Wu PH; Yu JR; Li W; Huang ZL; Wang JP; Zhao M
    Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Survival after Radiofrequency Ablation of Lung Oligometastases from Five Types of Primary Lesions: A Retrospective Evaluation.
    Omae K; Hiraki T; Gobara H; Iguchi T; Fujiwara H; Matsui Y; Toyooka S; Nagasaka T; Kanazawa S
    J Vasc Interv Radiol; 2016 Sep; 27(9):1362-1370. PubMed ID: 27461589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases.
    Gillams A; Khan Z; Osborn P; Lees W
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):724-30. PubMed ID: 23070108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.
    Veltri A; Basile D; Calandri M; Bertaggia C; Volante M; Porpiglia F; Calabrese A; Puglisi S; Basile V; Terzolo M
    Eur Radiol; 2020 Dec; 30(12):6958-6964. PubMed ID: 32621242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.
    de Baère T; Aupérin A; Deschamps F; Chevallier P; Gaubert Y; Boige V; Fonck M; Escudier B; Palussiére J
    Ann Oncol; 2015 May; 26(5):987-991. PubMed ID: 25688058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.